KIORA PHARMACEUTICALS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
KIORA PHARMACEUTICALS, INC. (KPRX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$4.23 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-04.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-03-04
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$2.15M.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.90M.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$2.70M.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $8.96M, a 41.59% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$4.23M, a 2232.87% decline from fiscal 2018.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $198.21K, a 95.25% decline from fiscal 2017.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $4.17M.
- KIORA PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$4.73M, a 157.54% decline from fiscal 2015.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | -$4.23M 10-K · filed 2020-03-04 | ||||
| 2019-03-31 | -$2.15M 10-Q · filed 2019-05-08 | -$4.04M derived: sum of 2 quarters · filed 2020-03-04 | -$6.75M derived: sum of 3 quarters · filed 2020-03-04 | $2.21M derived: sum of 4 quarters · filed 2020-03-04 | |
| 2018-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$4.60M derived: sum of 2 quarters · filed 2020-03-04 | $4.36M derived: sum of 3 quarters · filed 2020-03-04 | $198.21K 10-K · filed 2020-03-04 | |
| 2018-09-30 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.25M derived: sum of 2 quarters · filed 2018-11-13 | $2.09M 10-Q · filed 2018-11-13 | $655.52K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-06-30 | $8.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.80M 10-Q · filed 2018-08-03 | $3.36M derived: sum of 3 quarters · filed 2019-05-08 | $841.67K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | -$4.16M 10-Q · filed 2019-05-08 | -$5.60M derived: sum of 2 quarters · filed 2019-05-08 | -$8.11M derived: sum of 3 quarters · filed 2019-05-08 | -$1.79M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$3.96M derived: sum of 2 quarters · filed 2019-03-01 | $2.37M derived: sum of 3 quarters · filed 2019-03-01 | $4.17M 10-K · filed 2019-03-01 | |
| 2017-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.81M derived: sum of 2 quarters · filed 2018-11-13 | $5.61M 10-Q · filed 2018-11-13 | $3.59M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $6.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $8.13M 10-Q · filed 2018-08-03 | $6.11M derived: sum of 3 quarters · filed 2018-08-03 | $3.76M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $1.80M 10-Q · filed 2018-05-11 | -$219.70K derived: sum of 2 quarters · filed 2018-05-11 | -$2.56M derived: sum of 3 quarters · filed 2018-05-11 | -$1.75M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$4.37M derived: sum of 2 quarters · filed 2018-03-02 | -$3.55M derived: sum of 3 quarters · filed 2018-03-02 | -$4.73M 10-K · filed 2018-03-02 | -$4.76M 10-K · filed 2017-02-23 |
| 2016-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.53M derived: sum of 2 quarters · filed 2017-11-14 | -$2.71M 10-Q · filed 2017-11-14 | -$4.24M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $811.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$367.71K 10-Q · filed 2017-08-04 | -$1.89M derived: sum of 3 quarters · filed 2017-08-04 | $6.75M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | -$1.18M 10-Q · filed 2017-05-05 | -$2.70M derived: sum of 2 quarters · filed 2017-05-05 | $5.94M derived: sum of 3 quarters · filed 2017-05-05 | $4.93M derived: sum of 4 quarters · filed 2017-05-05 | |
| 2015-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $7.12M derived: sum of 2 quarters · filed 2017-02-23 | $6.11M derived: sum of 3 quarters · filed 2017-02-23 | $8.23M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $8.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $7.63M derived: sum of 2 quarters · filed 2016-11-01 | $9.75M 10-Q · filed 2016-11-01 | $9.61M derived: sum of 4 quarters · filed 2016-11-01 | |
| 2015-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $1.11M 10-Q · filed 2016-08-10 | $962.87K derived: sum of 3 quarters · filed 2016-08-10 | $872.14K derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | $2.12M 10-Q · filed 2016-05-13 | $1.97M derived: sum of 2 quarters · filed 2016-05-13 | $1.88M derived: sum of 3 quarters · filed 2016-05-13 | $1.76M derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | -$144.10K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$234.82K derived: sum of 2 quarters · filed 2016-03-30 | -$356.38K derived: sum of 3 quarters · filed 2016-03-30 | -$334.17K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$90.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$212.28K derived: sum of 2 quarters · filed 2015-11-12 | -$190.07K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$121.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$99.35K 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | $22.21K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |